Inovio Pharmaceuticals (INO) Earnings
Inovio Pharmaceuticals's next earnings report is expected on Tuesday, November 10, 2026 after the market closes, with EPS expected around -0.20.
Summary
In the quarter ended June 2026, Inovio Pharmaceuticals had revenue of $0, and diluted EPS of -0.07.
On August 12, 2026 it reported EPS of -0.07 against an estimate of -0.25 (beat).
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Next | Tue Nov 10, 2026 | After close | -0.20 | — | — |
| Last | Wed Aug 12, 2026 | — | -0.25 | -0.07 | Beat |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 9
| Company | Date | Time |
|---|---|---|
| Berkshire Hathaway Inc BRK-B | Mon Nov 9 | Reported |
| Cisco Systems Inc CSCO | Thu Nov 12 | After close |
| Applied Materials Inc AMAT | Thu Nov 12 | After close |
| Brookfield Corp BN | Thu Nov 12 | Before open |
| Constellation Energy Corp CEG | Mon Nov 9 | Reported |
| KKR & Co. Inc. KKR | Mon Nov 9 | Reported |
| Barrick Mining Corporation B | Mon Nov 9 | Reported |
| Petroleo Brasileiro Petrobras SA ADR PBR | Tue Nov 10 | After close |
Quarterly results
The last 12 quarters from Inovio Pharmaceuticals's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | — | -0.07 | — | — | 2026-08-12 |
| Mar 31, 2026 | $0 | — | -0.28 | — | — | 2026-05-13 |
| Dec 31, 2025 | $0 | — | — | — | — | 2026-03-12 |
| Sep 30, 2025 | $0 | — | -0.87 | — | — | 2025-11-10 |
| Jun 30, 2025 | $0 | — | -0.61 | — | — | 2025-08-12 |
| Mar 31, 2025 | $65,343 | — | -0.51 | — | -38337.0% | 2025-05-13 |
| Dec 31, 2024 | $116,994 | +14.0% | — | — | -17410.8% | 2025-03-18 |
| Sep 30, 2024 | $0 | — | -0.89 | — | — | 2024-11-14 |
| Jun 30, 2024 | $100,762 | -55.4% | -1.19 | — | -32945.9% | 2024-08-08 |
| Mar 31, 2024 | $0 | — | -1.31 | — | — | 2024-05-13 |
| Dec 31, 2023 | $102,651 | -17.7% | — | — | -26686.3% | 2024-03-06 |
| Sep 30, 2023 | $388,446 | -95.8% | -1.52 | — | -9152.6% | 2023-11-09 |
Questions about Inovio Pharmaceuticals
When does Inovio Pharmaceuticals report earnings?
Inovio Pharmaceuticals's next earnings report is expected on November 10, 2026 after the market closes.
Did Inovio Pharmaceuticals beat earnings estimates?
In its report on August 12, 2026, Inovio Pharmaceuticals beat the EPS estimate: -0.07 reported against -0.25 expected.
How did Inovio Pharmaceuticals do last quarter?
In the quarter ended June 2026, Inovio Pharmaceuticals had revenue of $0, and diluted EPS of -0.07.
From Inovio Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.